SCOPUS 정보 검색 플랫폼

Volumn 41, Issue 2, 2002, Pages 213-223

High-dose chemotherapy and autologous bone marrow transplantation in diffuse intermediate- and high-grade non-Hodgkin lymphoma

(2) Philip, Thierry a Biron, Pierre a

a CENTRE LÉON BÉRARD (France)

Author keywords

ABMT; High dose chemotherapy; Non Hodgkin lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE;

AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER GRADING; CLINICAL TRIAL; DRUG MEGADOSE; DRUG RESPONSE; HUMAN; MEDICAL LITERATURE; NONHODGKIN LYMPHOMA; RELAPSE; REVIEW;

ADULT; ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHOMA, DIFFUSE; LYMPHOMA, HIGH-GRADE; LYMPHOMA, INTERMEDIATE-GRADE; LYMPHOMA, NON-HODGKIN; MALE; NEOPLASM STAGING; REMISSION INDUCTION; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS;

EID: 0036169187 PISSN: 10408428 EISSN: None Source Type: Journal
DOI: 10.1016/S1040-8428(01)00158-5 Document Type: Review

Times cited : (8)

References (27)

1
- 0023197665
- High dose therapy and autologous bone marrow transplantation in 100 adults with intermediate and high-grade non Hodgkin's lymphoma
- (1987) N. Engl. J. Med. , vol.316 , pp. 1493-1498
- Philip, T.¹ Armitage, O.² Spitzer, G.³

2
- 0028790440
- Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma
- (1995) N. Engl. J. Med. , vol.333 , pp. 1540-1545
- Philip, T.¹ Guglielmi, C.² Hagenbeek, A.³

3
- 0022625255
- The role of massive therapy with autologous bone marrow transplantation in Burkitt lymphoma
- (1986) Clin. Hematol. , vol.15 , pp. 205-218
- Philip, T.¹ Pinkerton, R.² Hartmann, O.³

4
- 2042467594
- Philip T, Biron P, Philip I. Burkitt lymphoma an autologous bone marrow transplantation: overview. In: Dicke KA, Spitzer G, Zander AR, editors. Autologous Bone Marrow Transplantation, Proceedings of the First International Symposium, Houston, 1985;109-115.

5
- 0002281442
- Management of recurrent or refractory disease
- Magrath I. (Ed.), Non Hodgkin's Lymphomas, London: E Arnold
- (1990) , pp. 359-372
- Cabanillas, F.¹ Jagannath, S.² Philip, T.³

6
- 2042530179
- Philip T, Armitage O, Spitzer G, et al. An international randomized study of relapsed diffuse intermediate and high-grade lymphomas in adults. In: Dicke KA, Spitzer G, Jagannath S, editors. Autologous Bone Marrow Transplantation III, Proceedings of the Third International Symposium, Houston, 1987;313-333.

7
- 0025804084
- Role of high-dose chemotherapy and autologous bone marrow transplantation in the treatment of lymphoma
- (1991) Eur. J. Cancer , vol.27 , pp. 320-322
- Philip, T.¹ Biron, P.²

8
- 2042498867
- Eurostat 1997. News release, 1997;45:97-108.

9
- 0028180050
- Consensus conference on intensive chemotherapy plus hematopoietic stem cell transplantation in malignancies, Lyon, June 4-6, 1993
- (1994) Ann. Oncol. , vol.5 , pp. 19-23
- Coiffier, B.¹ Philip, T.² Burnett, A.K.³ Symann, M.M.⁴

10
- 0024043444
- High dose therapy and autologous bone marrow transplantation in partial response after first line induction therapy for diffuse non Hodgkin's lymphoma
- (1988) J. Clin. Oncol. , vol.6 , pp. 1118-1124
- Philip, T.¹ Hartmann, O.² Biron, P.³

11
- 0032951328
- International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury
- (1999) J. Clin. Oncol. , vol.17 , pp. 423-429
- Shipp, M.A.¹ Abeloff, M.D.² Antman, K.H.³

12
- 0031942894
- High-dose therapy for diffuse large-cell lymphoma in first remission
- (1998) Ann. Oncol. , vol.9 , Issue.Suppl 1
- Perry, A.¹ Goldstone, A.²

13
- 0031056945
- Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2
- (1997) J. Clin. Oncol. , vol.15 , pp. 1131-1137
- Haioun, C.¹ Lepage, E.² Gisselbrecht, C.³

14
- 0031879707
- VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the Non-Hodgkin's Lymphoma Cooperative Study Group
- (1998) J. Clin. Oncol. , vol.16 , pp. 2796-2802
- Santini, G.¹ Salvagno, L.² Leoni, P.³

15
- 0003209414
- Failure of first-line, inductive high-dose chemotherapy (HDC) in poor-risk patients (PTS) with aggressive lymphoma: Updated results of the randomized LNH93-3 study
- (1997) Blood , vol.90 , Issue.Suppl 1
- Reyes, F.¹ Lepage, E.² Morel, P.³

16
- 2042527692
- Kaiser U, Uebelacker I, Havemann K, on behalf of the German High-grade Lymphoma Study Group, Marburg, Germany. High dose chemotherapy with autologous stem cell transplantation in high-grade NHL: First analysis of a randomized multicenter study. Bone Marrow Transplant 1998;21 (Suppl 1):S177.

17
- 0030973746
- High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma
- (1997) N. Engl. J. Med. , vol.336 , pp. 1290-1297
- Gianni, A.¹ Bregni, M.² Siena, S.³

18
- 0028151441
- Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: A study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte
- (1994) J. Clin. Oncol. , vol.12 , pp. 2543-2551
- Haioun, C.¹ Lepage, E.² Gisselbrecht, C.³

19
- 0027285341
- Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose intensity combination chemotherapy
- (1993) J. Clin. Oncol. , vol.11 , pp. 943-949
- Waits, T.M.¹ Greco, F.A.² Greer, I.P.³

20
- 0028793717
- High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study
- (1995) J. Clin. Oncol. , vol.13 , pp. 2916-2923
- Shipp, M.¹ Neuberg, D.² Janicek, M.³ Canellos, G.P.⁴ Shulman, L.N.⁵

21
- 2042455030
- The International Non-Hodgidn's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993;329:987-994.

22
- 2042528510
- Blay JY, Gomez F, Sebban C, et al. on behalf of the PARMA group. The international prognostic index correlates to survival in patients with aggressive lymphoma in relapse: Analysis of the PARMA trial. Blood 1998;92:3562-3568.

23
- 2042500503
- Gugliemi C, Gomez F, Philip T, et al., on behalf of the PARMA cooperative group. Time to relapse has prognostic value in patients with aggressive lymphoma enrolled in the PARMA trial. J Clin Oncol 1998;16:3264-3269.

24
- 0027953370
- Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients: a case-controlled analysis of the EBMT Registry data. Lymphoma Working Party of the EBMT
- (1994) Ann. Oncol. , vol.5 , Issue.Suppl 2 , pp. 151-153
- Liberti, G.¹ Pearce, R.² Taghipour, G.³ Majolino, I.⁴ Goldstone, A.H.⁵

25
- 9044236159
- Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation in lymphoma patients
- (1996) Lancet , vol.347 , pp. 353-357
- Schmitz, N.¹ Linch, D.² Dreger, P.³

26
- 0030971387
- Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs
- (1997) Ann. Intern. Med. , vol.126 , pp. 600-607
- Hartmann, O.¹ Le Corroller, A.² Blaise, D.³

27
- 0008372382
- High-dose chemotherapy (HDC) and autotransplant for non-Hodgkin's lymphoma (NHL): randomized trial of peripheral blood (PSCT) versus bone marrow (ABMT) and evaluation of minimal residual disease (MRD)
- Abstr.
- (1997) Proc. Am. Soc. Clin. Oncol. , vol.16
- Vose, J.¹ Sharp, J.² Chan, W.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.